Crossmark Global Holdings’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-32,910
| Closed | -$648K | – | 1392 |
|
|
2021
Q3 | $648K | Sell |
32,910
-150
| -0.5% | -$2.95K | 0.02% | 792 |
|
|
2021
Q2 | $727K | Buy |
33,060
+180
| +0.5% | +$3.96K | 0.02% | 727 |
|
|
2021
Q1 | $782K | Buy |
32,880
+170
| +0.5% | +$4.04K | 0.02% | 685 |
|
|
2020
Q4 | $856K | Buy |
32,710
+10,274
| +46% | +$269K | 0.02% | 613 |
|
|
2020
Q3 | $390K | Buy |
22,436
+436
| +2% | +$7.58K | 0.01% | 886 |
|
|
2020
Q2 | $370K | Buy |
22,000
+1,700
| +8% | +$28.6K | 0.01% | 895 |
|
|
2020
Q1 | $241K | Hold |
20,300
| – | – | 0.01% | 964 |
|
|
2019
Q4 | $246K | Buy |
20,300
+870
| +4% | +$10.5K | 0.01% | 1233 |
|
|
2019
Q3 | $275K | Buy |
19,430
+190
| +1% | +$2.69K | 0.01% | 1101 |
|
|
2019
Q2 | $215K | Sell |
19,240
-870
| -4% | -$9.72K | 0.01% | 1267 |
|
|
2019
Q1 | $236K | Sell |
20,110
-110
| -0.5% | -$1.29K | 0.01% | 1242 |
|
|
2018
Q4 | $270K | Sell |
20,220
-14,610
| -42% | -$195K | 0.01% | 1138 |
|
|
2018
Q3 | $488K | Buy |
34,830
+450
| +1% | +$6.31K | 0.01% | 967 |
|
|
2018
Q2 | $540K | Buy |
34,380
+2,070
| +6% | +$32.5K | 0.01% | 895 |
|
|
2018
Q1 | $531K | Buy |
+32,310
| New | +$531K | 0.01% | 882 |
|